AstraZeneca says third dose helps against Omicron
AstraZeneca has established the vaccine with scientists from the University of Oxford, and lab studies performed by the university last month already found a three-dose course of Vaxzevria boosted antibody levels in the blood versus the rapidly spreading out Omicron version. The quick statement on Thursday, which did not consist of particular data, was the first by AstraZeneca on the protective potential of Vaxzevria as a booster shot following a two shot-course of either an mRNA based vaccine or Vaxzevria. AstraZeneca is trying to reveal the Beta-specific vaccine has capacity also versus other versions and more trial data is expected throughout the first half of the year.